SIM 0271
Alternative Names: SCR 7952; SIM-0271Latest Information Update: 25 Apr 2023
At a glance
- Originator Simcere Pharmaceutical Group
- Class Antineoplastics; Small molecules
- Mechanism of Action MAT2A protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours